A child presents with intermittent jaundice and splenomegaly. There is a history of similar complaints in the elder brother. Peripheral smear shows the following finding. How will you investigate this condition? La d

Correct Answer: A. Osmotic fragility test - Hereditary spherocytosis

The clinical presentation of intermittent jaundice, splenomegaly, and positive family history (elder brother affected) in a child is pathognomonic for hereditary spherocytosis (HS). The peripheral smear finding of spherocytes (dense, small RBCs lacking central pallor) is the morphological hallmark. HS is an autosomal dominant condition affecting RBC membrane proteins (spectrin, ankyrin, band 3), causing loss of biconcave shape and increased osmotic fragility. The osmotic fragility test is the gold-standard diagnostic investigation: spherocytes lyse at higher osmotic pressures (hypotonic solutions) compared to normal RBCs because their reduced surface-area-to-volume ratio limits water accommodation. In India, this test remains the first-line confirmatory test in resource-limited settings before flow cytometry. The intermittent jaundice reflects hemolytic episodes triggered by infections or stress, while splenomegaly results from extramedullary erythropoiesis and RBC sequestration. Family history of similar presentation in the sibling confirms the hereditary nature and rules out acquired hemolytic anemias.

Why the other options are wrong

B. Paroxysmal nocturnal hemoglobinuria - Flow cytometry — PNH presents with dark urine (hemoglobinuria), thrombosis, and cytopenias—not splenomegaly or family history. Flow cytometry detects CD55/CD59 deficiency on blood cells, but PNH is acquired, not hereditary. The absence of thrombotic complications and hemoglobinuria makes this unlikely. NBE pairs flow cytometry with PNH to trap students who confuse modern diagnostic modalities with clinical presentation. C. Coombs test - AIHA — AIHA (autoimmune hemolytic anemia) is acquired and lacks family history; it presents with positive direct Coombs test (IgG/complement on RBC surface). The peripheral smear shows polychromasia and spherocytes, but spherocytes in AIHA are secondary to antibody coating, not intrinsic membrane defects. The strong family history and hereditary pattern exclude AIHA, which is sporadic in children. D. G6PD deficiency - Genetic testing — G6PD deficiency causes acute hemolytic crises triggered by oxidative stress (fava beans, infections, drugs), not chronic intermittent jaundice with baseline splenomegaly. G6PD is X-linked recessive (rare in females, affects males predominantly), whereas HS is autosomal dominant with both sexes equally affected. Peripheral smear in G6PD shows Heinz bodies and bite cells, not spherocytes. Genetic testing is not the first-line investigation for G6PD; fluorescent spot test or enzyme assay is.

High-Yield Facts

Mnemonics

HS vs. AIHA (Spherocytes Differential) HS = Hereditary, Hyperosmotic lysis, Haptoglobin normal (early), History positive. AIHA = Acquired, Antibody-coated, Antiglobulin positive, Acute onset. Use when you see spherocytes on smear—ask: family history? → HS; positive Coombs? → AIHA. Osmotic Fragility Mnemonic 'Spheres Sink Sooner' — Spherocytes lyse at higher osmotic pressures (lower NaCl %) because their reduced surface area cannot accommodate water influx like normal biconcave RBCs. Test at 0.36–0.40% NaCl for HS vs. 0.44–0.48% for normal.

NBE Trap

NBE pairs modern diagnostic modalities (flow cytometry, genetic testing) with rare hemolytic anemias to distract from the classic clinical presentation of HS. The key trap: recognizing that osmotic fragility test remains the first-line confirmatory test in Indian clinical practice, despite flow cytometry being more specific. Students who over-rely on "newer = better" diagnostics fall into this trap.

Clinical Pearl

In Indian pediatric practice, a child presenting with recurrent jaundice and splenomegaly should raise suspicion for HS immediately if family history is positive. Many Indian children with HS present during monsoon (infection-triggered hemolytic crisis); osmotic fragility testing in a primary health center can confirm diagnosis before referral for splenectomy, which is curative in symptomatic cases.

_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 12 (Red Blood Cell Disorders); Harrison's Principles of Internal Medicine, Ch. 99 (Hemolytic Anemias); KD Tripathi Essentials of Medical Pharmacology, Ch. 8 (Hematopoietic agents—relevant for HS management context)._